Pediatric UC, Adacolumn apheresis
Showing 1 - 25 of >10,000
National GMA Post-market Clinical Follow-up Study (GRACE)
Recruiting
- Crohn Disease
- Ulcerative Colitis
- Adacolumn
-
Badalona, Barcelona, Spain
- +28 more
Nov 24, 2022
Ulcerative Colitis Trial in Portugal, Spain (Adacolumn)
Recruiting
- Ulcerative Colitis
- Adacolumn
-
Coimbra, Portugal
- +9 more
Jun 22, 2022
Ulcerative Colitis Trial in Wuhan (Fecal Microbiota Transplantation)
Recruiting
- Ulcerative Colitis
- Fecal Microbiota Transplantation
-
Wuhan, ChinaTongji Hospital
Jan 30, 2023
Ulcerative Colitis Trial in Kfar Saba (Adding household bleach to urine sample)
Active, not recruiting
- Ulcerative Colitis
- Adding household bleach to urine sample
-
Kfar Saba, IsraelMeir Medical Center
Aug 24, 2023
Ulcerative Colitis Trial (Mirikizumab IV, Mirikizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Mirikizumab IV
- Mirikizumab SC
- (no location specified)
Mar 24, 2023
Ulcerative Colitis Trial in Pittsburgh (Nicotinamide Riboside Chloride, Placebo, Standard of Care)
Not yet recruiting
- Ulcerative Colitis
- Nicotinamide Riboside Chloride
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Oct 7, 2022
Exclusive Enteral Nutrition, Ulcerative Colitis, Children Trial (exclusive enteral nutrition, regular food)
Not yet recruiting
- Exclusive Enteral Nutrition
- +2 more
- exclusive enteral nutrition
- regular food
- (no location specified)
Dec 5, 2022
LDL-Apheresis for FSGS CardioRenal Outcomes
Enrolling by invitation
- Focal Segmental Glomerulosclerosis
- No intervention
-
Cincinnati, Ohio
- +1 more
Jan 25, 2023
Tolerance of Therapeutic Apheresis in Paediatric
Completed
- Apheresis Related Complication
- Efficacy of apheresis
-
Montpellier, FranceUh Montpellier
Apr 11, 2022
Colitis, Ulcerative Trial in Worldwide (Ustekinumab Dose Based on BSA and Body Weight, Matching Placebo)
Recruiting
- Colitis, Ulcerative
- Ustekinumab Dose Based on BSA and Body Weight
- Matching Placebo
-
Wilmington, Delaware
- +68 more
Jan 31, 2023
Therapeutic Endpoint in Pediatric IBD Conditions
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- AlgometRx Nociometer
- (no location specified)
Sep 27, 2023
Ulcerative Colitis (UC) Trial in Puerto Rico, United States (Mesalamine, Placebo)
Not yet recruiting
- Ulcerative Colitis (UC)
- Mesalamine
- Placebo
-
Washington, District of Columbia
- +9 more
Nov 21, 2022
Ulcerative Colitis Trial (High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching rectal foam)
Not yet recruiting
- Ulcerative Colitis
- High dose budesonide rectal foam
- +2 more
- (no location specified)
Jul 28, 2023
Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV)
Not yet recruiting
- Ulcerative Colitis
- Crohn's Disease
- Vedolizumab IV
- (no location specified)
Jul 21, 2022
IBD, Crohn Disease, Ulcerative Colitis Trial in Orléans (Blood and fecal samples, Coolonic biopsies)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Blood and fecal samples
- Coolonic biopsies
-
Orléans, FranceCHR Orléans
Jun 14, 2023
Sickle Cell Disease Trial in Memphis (Plerixafor)
Recruiting
- Sickle Cell Disease
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 11, 2023
Ozanimod Exposure During Pregnancy in Ulcerative Colitis and
Not yet recruiting
- Ulcerative Colitis
- Ozanimod
- +2 more
-
Eden Prairie, MinnesotaOptumInsight Life Sciences Inc
Nov 9, 2023
Ulcerative Colitis Trial (Low Dose Budesonide, High Dose Budesonide, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Low Dose Budesonide
- +2 more
- (no location specified)
Sep 7, 2022
Vascular Access Complications for Therapeutic Apheresis in
Recruiting
- Vascular Access Complication
- Apheresis Related Complication
-
Nancy, FranceCentral Hospital
May 30, 2023